Exhibit 23.2

 NOTICE REGARDING CONSENT OF ARTHUR ANDERSEN LLP


Section 11(a) of the Securities Act of 1933, as amended
(the "Securities Act"), provides that if any part of a
registration statement at the time such part becomes
effective contains an untrue statement of a material fact
or an omission to state a material fact required to be
stated therein or necessary to make the statements
therein not misleading, any person acquiring a security
pursuant to such registration statement (unless it is
proved that at the time of such acquisition such person
knew of such untruth or omission) may sue, among others,
every accountant who has consented to be named as having
prepared or certified any part of the registration
statement, or as having prepared or certified any report
or valuation which is used in connection with the
registration statement, with respect to the statement in
such registration statement, report or valuation which
purports to have been prepared or certified by the
accountant.

As previously disclosed in the HemaCare Corporation's
form 8-K filed on June 27, 2002, HemaCare Corporation
dismissed Arthur Andersen LLP as its independent public
accountants and announced that the Company had appointed
Ernst & Young LLP to replace Arthur Andersen LLP as its
independent public accountants.

HemaCare's understanding is that the staff of the
Securities and Exchange Commission has taken the position
that it will not accept consents from Arthur Andersen LLP
if the engagement partner and the manager for the
HemaCare Corporation audit are no longer with Arthur
Andersen LLP. Both the engagement partner and the manager
for the HemaCare Corporation audit are no longer with
Arthur Andersen LLP. As a result, HemaCare has been
unable to obtain Arthur Andersen LLP's written consent to
the incorporation by reference into the Registration
Statements of its audit report with respect to the
Company's financial statements as of December 31, 2001
and 2000 for the years then ended.

Under these circumstances, Rule 437a under the Securities
Act permits HemaCare Corporation to file this Form 10-K
without a written consent from Arthur Andersen LLP. As a
result, however, Arthur Andersen LLP will not have any
liability under Section 11(a) of the Securities Act for
any untrue statements of a material fact contained in the
financial statements audited by Arthur Andersen LLP or
any omissions of a material fact required to be stated
therein. Accordingly, you would be unable to assert a
claim against Arthur Andersen LLP under Section 11(a) of
the Securities Act for any purchases of securities under
the Registration Statements made on or after the date of
this Form 10-K. To the extent provided in Section
11(b)(3)(C) of the Securities Act, however, other persons
who are liable under Section 11(a) of the Securities Act,
including the Company's officers and directors, may still
rely on Arthur Andersen LLP's original audit reports as
being made by an expert for purposes of establishing a
due diligence defense under Section 11(b) of the
Securities Act.